World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
85
Citations
44707
World Ranking
14360
National Ranking
1329

Raashid Luqmani publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where Raashid Luqmani sits on this spectrum.

101–120 publications: 5 scientists 121–140 publications: 26 scientists 141–160 publications: 73 scientists 161–180 publications: 155 scientists 181–200 publications: 230 scientists 201–220 publications: 363 scientists 221–240 publications: 487 scientists 241–260 publications: 545 scientists 261–280 publications: 722 scientists 281–300 publications: 768 scientists 301–320 publications: 834 scientists 321–340 publications: 895 scientists 341–360 publications: 922 scientists 361–380 publications: 838 scientists 381–400 publications: 861 scientists 401–420 publications: 918 scientists 421–440 publications: 806 scientists 441–460 publications: 771 scientists 461–480 publications: 751 scientists 481–500 publications: 713 scientists 501–520 publications: 617 scientists 521–540 publications: 611 scientists 541–560 publications: 537 scientists 561–580 publications: 504 scientists 581–600 publications: 509 scientists 601–620 publications: 396 scientists 621–640 publications: 386 scientists 641–660 publications: 371 scientists 661–680 publications: 340 scientists 681–700 publications: 336 scientists 701–720 publications: 307 scientists 721–740 publications: 259 scientists 741–760 publications: 230 scientists 761–780 publications: 228 scientists 781–800 publications: 217 scientists 801–820 publications: 204 scientists 821–840 publications: 186 scientists 841–860 publications: 177 scientists 861–880 publications: 155 scientists 881–900 publications: 139 scientists 901–920 publications: 145 scientists 921–940 publications: 116 scientists 941–960 publications: 133 scientists 961–980 publications: 91 scientists 981–1,000 publications: 96 scientists 1,001–1,020 publications: 77 scientists 1,021–1,040 publications: 70 scientists 1,041–1,060 publications: 63 scientists 1,061–1,080 publications: 77 scientists 1,081–1,100 publications: 49 scientists 1,101–1,120 publications: 54 scientists 1,121–1,140 publications: 49 scientists 1,141–1,160 publications: 51 scientists 1,161–1,180 publications: 35 scientists 1,181–1,200 publications: 39 scientists 1,201–1,220 publications: 26 scientists 1,221–1,240 publications: 37 scientists 1,241–1,260 publications: 36 scientists 1,261–1,280 publications: 27 scientists 1,281–1,300 publications: 32 scientists 1,301–1,320 publications: 28 scientists 1,321–1,340 publications: 17 scientists 1,341–1,360 publications: 30 scientists 1,361–1,380 publications: 28 scientists 1,381–1,400 publications: 17 scientists 1,401–1,420 publications: 21 scientists 1,421–1,440 publications: 15 scientists 1,441–1,460 publications: 12 scientists 1,461–1,480 publications: 12 scientists 1,481–1,500 publications: 18 scientists 1,501–1,520 publications: 14 scientists 1,521–1,540 publications: 17 scientists 1,541–1,560 publications: 15 scientists 1,561–1,580 publications: 6 scientists 1,581–1,600 publications: 2 scientists 1,601–1,620 publications: 12 scientists 1,621–1,640 publications: 11 scientists 1,641–1,660 publications: 8 scientists 1,661–1,680 publications: 5 scientists 1,681–1,700 publications: 5 scientists 1,701–1,720 publications: 10 scientists 1,721–1,740 publications: 12 scientists 1,741–1,760 publications: 14 scientists 1,761–1,780 publications: 6 scientists 1,781–1,795 publications: 5 scientists 1,796+ publications: 100 scientists
101 publications 1,796+

This scientist: 532 publications — 63rd percentile

63% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,796 publications or more.

Raashid Luqmani D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where Raashid Luqmani sits on this spectrum.

70–71 D-Index: 226 scientists 72–73 D-Index: 391 scientists 74–75 D-Index: 574 scientists 76–77 D-Index: 730 scientists 78–79 D-Index: 891 scientists 80–81 D-Index: 972 scientists 82–83 D-Index: 1,027 scientists 84–85 D-Index: 1,003 scientists 86–87 D-Index: 960 scientists 88–89 D-Index: 970 scientists 90–91 D-Index: 922 scientists 92–93 D-Index: 839 scientists 94–95 D-Index: 808 scientists 96–97 D-Index: 779 scientists 98–99 D-Index: 668 scientists 100–101 D-Index: 611 scientists 102–103 D-Index: 630 scientists 104–105 D-Index: 513 scientists 106–107 D-Index: 541 scientists 108–109 D-Index: 445 scientists 110–111 D-Index: 429 scientists 112–113 D-Index: 400 scientists 114–115 D-Index: 393 scientists 116–117 D-Index: 318 scientists 118–119 D-Index: 302 scientists 120–121 D-Index: 287 scientists 122–123 D-Index: 255 scientists 124–125 D-Index: 256 scientists 126–127 D-Index: 252 scientists 128–129 D-Index: 230 scientists 130–131 D-Index: 179 scientists 132–133 D-Index: 168 scientists 134–135 D-Index: 163 scientists 136–137 D-Index: 159 scientists 138–139 D-Index: 134 scientists 140–141 D-Index: 134 scientists 142–143 D-Index: 118 scientists 144–145 D-Index: 109 scientists 146–147 D-Index: 106 scientists 148–149 D-Index: 74 scientists 150–151 D-Index: 79 scientists 152–153 D-Index: 80 scientists 154–155 D-Index: 87 scientists 156–157 D-Index: 57 scientists 158–159 D-Index: 74 scientists 160–161 D-Index: 69 scientists 162–163 D-Index: 60 scientists 164–165 D-Index: 53 scientists 166–167 D-Index: 39 scientists 168–169 D-Index: 42 scientists 170–171 D-Index: 32 scientists 172–173 D-Index: 39 scientists 174–175 D-Index: 40 scientists 176–177 D-Index: 28 scientists 178–179 D-Index: 19 scientists 180–181 D-Index: 23 scientists 182–183 D-Index: 31 scientists 184–185 D-Index: 18 scientists 186–187 D-Index: 20 scientists 188–189 D-Index: 22 scientists 190–191 D-Index: 13 scientists 192–193 D-Index: 21 scientists 194–195 D-Index: 12 scientists 196–197 D-Index: 12 scientists 198–199 D-Index: 14 scientists 200–201 D-Index: 15 scientists 202–203 D-Index: 13 scientists 204–205 D-Index: 10 scientists 206–207 D-Index: 8 scientists 208–209 D-Index: 4 scientists 210–211 D-Index: 12 scientists 212–213 D-Index: 11 scientists 214–215 D-Index: 10 scientists 216 D-Index: 4 scientists 217+ D-Index: 98 scientists
70 D-Index 217+

This scientist: 85 D-Index — 29th percentile

29% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 217 D-Index or more.

Overview

Raashid Luqmani is affiliated with the University of Oxford in the United Kingdom. Their research contributions primarily fall within the field of Medicine, with a strong focus on Rheumatology and related subfields such as Pulmonary and Respiratory Medicine, Genetics, Nephrology, and Immunology.

The main topics of Luqmani's work include:

  • Vasculitis and related conditions
  • Otitis Media and Relapsing Polychondritis
  • Coagulation, Bradykinin, Polyphosphates, and Angioedema
  • Renal Diseases and Glomerulopathies
  • Urticaria and Related Conditions
  • Sarcoidosis and Beryllium Toxicity Research
  • Inflammasome and immune disorders

Raashid Luqmani has contributed to a number of recent publications, including:

  • 2012 Revised International Chapel Hill Consensus Conference Nomenclature of Vasculitides (2020), published in UNC Libraries
  • EULAR recommendations for the management of ANCA-associated vasculitis: 2022 update (2023), published in Annals of the Rheumatic Diseases
  • 2022 American College of Rheumatology/European Alliance of Associations for Rheumatology Classification Criteria for Eosinophilic Granulomatosis with Polyangiitis (2022), published in Annals of the Rheumatic Diseases
  • 2022 American College of Rheumatology/European Alliance of Associations for Rheumatology classification criteria for granulomatosis with polyangiitis (2022), published in Annals of the Rheumatic Diseases
  • 2022 American College of Rheumatology/European Alliance of Associations for Rheumatology classification criteria for microscopic polyangiitis (2022), published in Annals of the Rheumatic Diseases

The scientist frequently collaborates with several co-authors, including:

  • Peter A. Merkel
  • Cristina Ponte
  • Richard A. Watts
  • Anthea Craven
  • Peter C. Grayson

Their publications are often found in specific scholarly venues, such as:

  • Annals of the Rheumatic Diseases
  • Lara D. Veeken
  • Arthritis & Rheumatology
  • RMD Open
  • Nephrology Dialysis Transplantation

Raashid Luqmani's work demonstrates a multidisciplinary approach within medicine, emphasizing complex immune and inflammatory conditions particularly related to vasculitis and associated autoimmune diseases.

Best Publications

  • 2012 Revised International Chapel Hill Consensus Conference Nomenclature of Vasculitides

    J. C. Jennette;R. J. Falk;P. A. Bacon;N. Basu

  • Rituximab versus Cyclophosphamide in ANCA-Associated Renal Vasculitis

    Rachel B. Jones;Jan Willem Cohen Tervaert;Thomas Hauser;Raashid Luqmani

  • EULAR Recommendations for the management of primary small and medium vessel vasculitis

    C. Mukhtyar;L. Guillevin;M. C. Cid;B. Dasgupta

  • Birmingham Vasculitis Activity Score (BVAS) in systemic necrotizing vasculitis.

    R A Luqmani;P A Bacon;R J Moots;B A Janssen

  • EULAR/ERA-EDTA recommendations for the management of ANCA-associated vasculitis.

    M. Yates;M. Yates;R. A. Watts;I. M. Bajema;M. C. Cid

  • Revised international Chapel Hill consensus conference nomenclature of vasculitides

    J. C. Jennette;R. J. Falk;P. Bacon;N Basu

  • Modification and validation of the Birmingham Vasculitis Activity Score (version 3)

    Chetan Mukhtyar;Robert Lee;Denise Brown;David Carruthers

  • Mepolizumab or Placebo for Eosinophilic Granulomatosis with Polyangiitis

    Michael E. Wechsler;Praveen Akuthota;David Jayne;Paneez Khoury

  • Long-term patient survival in ANCA-associated vasculitis

    Oliver Flossmann;Annelies Berden;Kirsten de Groot;Chris Hagen

  • Randomized trial of cyclophosphamide versus methotrexate for induction of remission in early systemic antineutrophil cytoplasmic antibody–associated vasculitis

    Kirsten De Groot;Niels Rasmussen;Paul A Bacon;Jan Willem Cohen Tervaert

  • 2018 Update of the EULAR recommendations for the management of large vessel vasculitis.

    Bernhard Hellmich;Ana Agueda;Sara Monti;Frank Buttgereit

  • Granulomatosis with polyangiitis (Wegener's): an alternative name for Wegener's granulomatosis.

    Ronald J. Falk;Wolfgang L. Gross;Loïc Guillevin;Gary S. Hoffman

  • EULAR recommendations for the management of large vessel vasculitis

    C. Mukhtyar;L. Guillevin;M. C. Cid;B. Dasgupta

  • 2012 Provisional classification criteria for polymyalgia rheumatica: A European League Against Rheumatism/American College of Rheumatology collaborative initiative†

    Bhaskar Dasgupta;Marco A. Cimmino;Hilal Maradit Kremers;Wolfgang A. Schmidt

  • EULAR recommendations for conducting clinical studies and/or clinical trials in systemic vasculitis: focus on anti-neutrophil cytoplasm antibody-associated vasculitis

    Bernhard Hellmich;Oliver Flossmann;Wolfgang L Gross;Paul Bacon

  • 2012 provisional classification criteria for polymyalgia rheumatica: a European League Against Rheumatism/American College of Rheumatology collaborative initiative

    Bhaskar Dasgupta;Marco A Cimmino;Hilal Maradit-Kremers;Wolfgang A Schmidt

  • Development and initial validation of the vasculitis damage index for the standardized clinical assessment of damage in the systemic vasculitides

    A. R. Exley;P. A. Bacon;R. A. Luqmani;G. D. Kitas

  • A multicenter, randomized, double-blind, placebo-controlled trial of adjuvant methotrexate treatment for giant cell arteritis.

    Gary S. Hoffman;Maria C. Cid;David B. Hellmann;Loic Guillevin

  • Eular recommendations for conducting clinical studies and/or clinical trials in systemic vasculitis

    B Hellmich;O Flossmann;R Luqmani

  • Validation of the Birmingham Vasculitis Activity Score (Version 3)

    Chetan Bhikhubhai Mukhtyar;Raashid Luqmani;Afsie Sabokbar

Frequent Co-Authors

Peter A. Merkel
Peter A. Merkel University of Pennsylvania
Richard A. Watts
Richard A. Watts University of East Anglia
David Jayne
David Jayne University of Cambridge
Alfred Mahr
Alfred Mahr Université Paris Cité
Maria C. Cid
Maria C. Cid University of Barcelona
Andrew Judge
Andrew Judge University of Bristol
Ulrich Specks
Ulrich Specks Mayo Clinic
Gary S. Hoffman
Gary S. Hoffman Cleveland Clinic
Loïc Guillevin
Loïc Guillevin Université Paris Cité
Paul Emery
Paul Emery University of Leeds

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring a future in medicine doesn’t always mean attending traditional, on-campus programs. Many accredited nursing school online options exist, offering flexibility and affordability to aspiring healthcare professionals.

For registered nurses looking to advance, the rn to bsn online route provides an accessible way to earn your bachelor’s degree while continuing to work. Those seeking higher-level leadership or clinical roles might consider the cheapest dnp programs available online, which open doors to specialized and executive positions in healthcare.

If you hold a non-nursing bachelor’s degree but want to shift into nursing, direct entry msn programs online can be a fast-track solution. These alternative learning pathways make it easier to begin or advance a medical career without being bound by geography or rigid schedules.

Choosing the right online degree can help you start or advance your healthcare journey, making medical and nursing education more accessible than ever.

Best Scientists Citing Raashid Luqmani

Trending Scientists

Recently Published Articles